Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Srdan Verstovsek, M.D., Ph.D.
MD Anderson Cancer Center, Houston, TX, 77030
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Scottsdale Recruiting
Scottsdale, Arizona, United States
- Uc San Diego Moores Cancer Center
San Diego, California, United States
- Mayo Clinic, Jacksonville
Jacksonville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Chicago
Chicago, Illinois, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Weill Cornell Medical College
New York, New York, United States
- Md Anderson Cancer Center, Department of Leukemia
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2011
- Primary completion
- 22 Apr 2020
- Completion
- 22 Apr 2020
- Last update posted
- 9 Mar 2022
- Registered enrollment
- 77
- Registry id
- NCT01423851
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.